Viral vectors are widely used in gene therapies. The viral vectors are majorly used by researchers to deliver genetic materials in the cells. Viral vectors are playing significant role in the pharmaceutical sector, as many research and innovations are ongoing for the development of drugs for treating cancer, cardiovascular diseases, ophthalmology, hematology, and many others.
The global market for Viral Vector and Plasmid DNA Testing Service was estimated to be worth US$ 234.5 million in 2023 and is forecast to a readjusted size of US$ 1039.6 million by 2030 with a CAGR of 23.5% during the forecast period 2024-2030
The Viral Vector and Plasmid DNA Testing Service market is driven by the increasing demand for accurate and reliable testing services to ensure the safety and quality of gene therapies and vaccines using viral vectors and plasmid DNA. Testing services play a crucial role in assessing the potency, purity, and identity of these biopharmaceutical products before clinical use. The growing focus on gene-based therapies and the development of innovative treatments for various diseases contribute to market growth. Moreover, regulatory requirements mandating stringent testing standards further propel adoption. However, challenges include the complexity of testing methods and the need for specialized expertise and equipment. Addressing potential cross-contamination, ensuring consistency in testing results, and adhering to evolving regulatory guidelines are ongoing concerns. The market's success relies on continuous research to develop advanced testing methodologies, robust quality control measures, and collaborations between testing laboratories and pharmaceutical companies to offer accurate, efficient, and compliant viral vector and plasmid DNA testing services while navigating the evolving challenges associated with biopharmaceutical testing.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Viral Vector and Plasmid DNA Testing Service, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Vector and Plasmid DNA Testing Service by region & country, by Type, and by Application.
The Viral Vector and Plasmid DNA Testing Service market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector and Plasmid DNA Testing Service.
Market Segmentation
By Company
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
Segment by Type:
Safety
Genetic Characterization
Purity
Identity
Potency
Segment by Application
Research Organizations
Pharmaceutical
Biotechnological Companies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Vector and Plasmid DNA Testing Service manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Viral Vector and Plasmid DNA Testing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Viral Vector and Plasmid DNA Testing Service in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Viral Vector and Plasmid DNA Testing Service Product Introduction
1.2 Global Viral Vector and Plasmid DNA Testing Service Market Size Forecast
1.3 Viral Vector and Plasmid DNA Testing Service Market Trends & Drivers
1.3.1 Viral Vector and Plasmid DNA Testing Service Industry Trends
1.3.2 Viral Vector and Plasmid DNA Testing Service Market Drivers & Opportunity
1.3.3 Viral Vector and Plasmid DNA Testing Service Market Challenges
1.3.4 Viral Vector and Plasmid DNA Testing Service Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Vector and Plasmid DNA Testing Service Players Revenue Ranking (2023)
2.2 Global Viral Vector and Plasmid DNA Testing Service Revenue by Company (2019-2024)
2.3 Key Companies Viral Vector and Plasmid DNA Testing Service Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Vector and Plasmid DNA Testing Service Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Vector and Plasmid DNA Testing Service
2.6 Viral Vector and Plasmid DNA Testing Service Market Competitive Analysis
2.6.1 Viral Vector and Plasmid DNA Testing Service Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Viral Vector and Plasmid DNA Testing Service Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector and Plasmid DNA Testing Service as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Safety
3.1.2 Genetic Characterization
3.1.3 Purity
3.1.4 Identity
3.1.5 Potency
3.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type
3.2.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Type (2019-2030)
3.2.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Organizations
4.1.2 Pharmaceutical
4.1.3 Biotechnological Companies
4.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application
4.2.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Application (2019-2030)
4.2.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region
5.1.1 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2019-2024)
5.1.3 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (2025-2030)
5.1.4 Global Viral Vector and Plasmid DNA Testing Service Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.2.2 North America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.3.2 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.4.2 Asia Pacific Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.5.2 South America Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
5.6.2 Middle East & Africa Viral Vector and Plasmid DNA Testing Service Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Viral Vector and Plasmid DNA Testing Service Sales Value
6.3 United States
6.3.1 United States Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.3.2 United States Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.4.2 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.5.2 China Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.5.3 China Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.6.2 Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.7.2 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.8.2 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Viral Vector and Plasmid DNA Testing Service Sales Value, 2019-2030
6.9.2 India Viral Vector and Plasmid DNA Testing Service Sales Value by Type (%), 2023 VS 2030
6.9.3 India Viral Vector and Plasmid DNA Testing Service Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 BioReliance
7.1.1 BioReliance Profile
7.1.2 BioReliance Main Business
7.1.3 BioReliance Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.1.4 BioReliance Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.1.5 BioReliance Recent Developments
7.2 Cobra Biologics
7.2.1 Cobra Biologics Profile
7.2.2 Cobra Biologics Main Business
7.2.3 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.2.4 Cobra Biologics Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.2.5 Cobra Biologics Recent Developments
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Profile
7.3.2 Oxford BioMedica Main Business
7.3.3 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.3.4 Oxford BioMedica Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.3.5 UniQure Recent Developments
7.4 UniQure
7.4.1 UniQure Profile
7.4.2 UniQure Main Business
7.4.3 UniQure Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.4.4 UniQure Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.4.5 UniQure Recent Developments
7.5 FinVector
7.5.1 FinVector Profile
7.5.2 FinVector Main Business
7.5.3 FinVector Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.5.4 FinVector Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.5.5 FinVector Recent Developments
7.6 MolMed
7.6.1 MolMed Profile
7.6.2 MolMed Main Business
7.6.3 MolMed Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.6.4 MolMed Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.6.5 MolMed Recent Developments
7.7 MassBiologics
7.7.1 MassBiologics Profile
7.7.2 MassBiologics Main Business
7.7.3 MassBiologics Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.7.4 MassBiologics Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.7.5 MassBiologics Recent Developments
7.8 Richter-Helm
7.8.1 Richter-Helm Profile
7.8.2 Richter-Helm Main Business
7.8.3 Richter-Helm Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.8.4 Richter-Helm Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.8.5 Richter-Helm Recent Developments
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Profile
7.9.2 FUJIFILM Diosynth Biotechnologies Main Business
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
7.10 Lonza
7.10.1 Lonza Profile
7.10.2 Lonza Main Business
7.10.3 Lonza Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.10.4 Lonza Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.10.5 Lonza Recent Developments
7.11 Aldevron
7.11.1 Aldevron Profile
7.11.2 Aldevron Main Business
7.11.3 Aldevron Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.11.4 Aldevron Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.11.5 Aldevron Recent Developments
7.12 Eurogentec
7.12.1 Eurogentec Profile
7.12.2 Eurogentec Main Business
7.12.3 Eurogentec Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.12.4 Eurogentec Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.12.5 Eurogentec Recent Developments
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Profile
7.13.2 Cell and Gene Therapy Catapult Main Business
7.13.3 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.13.4 Cell and Gene Therapy Catapult Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.13.5 Cell and Gene Therapy Catapult Recent Developments
7.14 Biovian
7.14.1 Biovian Profile
7.14.2 Biovian Main Business
7.14.3 Biovian Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.14.4 Biovian Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.14.5 Biovian Recent Developments
7.15 Brammer Bio
7.15.1 Brammer Bio Profile
7.15.2 Brammer Bio Main Business
7.15.3 Brammer Bio Viral Vector and Plasmid DNA Testing Service Products, Services and Solutions
7.15.4 Brammer Bio Viral Vector and Plasmid DNA Testing Service Revenue (US$ Million) & (2019-2024)
7.15.5 Brammer Bio Recent Developments
8 Industry Chain Analysis
8.1 Viral Vector and Plasmid DNA Testing Service Industrial Chain
8.2 Viral Vector and Plasmid DNA Testing Service Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Vector and Plasmid DNA Testing Service Sales Model
8.5.2 Sales Channel
8.5.3 Viral Vector and Plasmid DNA Testing Service Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
听
听
*If Applicable.
